Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Working Capital Changes (2016 - 2022)

Historic Other Working Capital Changes for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Q4 2022 value amounting to -$3.0 million.

  • Avadel Pharmaceuticals' Other Working Capital Changes fell 30010000.0% to -$3.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$31.0 million, marking a year-over-year decrease of 303364.93%. This contributed to the annual value of -$828000.0 for FY2024, which is 13842.23% down from last year.
  • As of Q4 2022, Avadel Pharmaceuticals' Other Working Capital Changes stood at -$3.0 million, which was down 30010000.0% from -$14.6 million recorded in Q3 2022.
  • Avadel Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $6.4 million during Q4 2018, with a 5-year trough of -$15.4 million in Q2 2022.
  • For the 5-year period, Avadel Pharmaceuticals' Other Working Capital Changes averaged around -$1.3 million, with its median value being -$618500.0 (2018).
  • In the last 5 years, Avadel Pharmaceuticals' Other Working Capital Changes skyrocketed by 51557.29% in 2021 and then plummeted by 30010000.0% in 2022.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Other Working Capital Changes stood at $6.4 million in 2018, then tumbled by 110.53% to -$672000.0 in 2019, then skyrocketed by 84.52% to -$104000.0 in 2020, then surged by 99.04% to -$1000.0 in 2021, then crashed by 300100.0% to -$3.0 million in 2022.
  • Its Other Working Capital Changes was -$3.0 million in Q4 2022, compared to -$14.6 million in Q3 2022 and -$15.4 million in Q2 2022.